194 related articles for article (PubMed ID: 36551152)
1. Current Progress of EMT: A New Direction of Targeted Therapy for Colorectal Cancer with Invasion and Metastasis.
Tan Z; Sun W; Li Y; Jiao X; Zhu M; Zhang J; Qing C; Jia Y
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551152
[TBL] [Abstract][Full Text] [Related]
2. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.
Zhang JX; Mai SJ; Huang XX; Wang FW; Liao YJ; Lin MC; Kung HF; Zeng YX; Xie D
Ann Oncol; 2014 Nov; 25(11):2196-2204. PubMed ID: 25193986
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
4.
Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
[TBL] [Abstract][Full Text] [Related]
5. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
Li H; Rokavec M; Jiang L; Horst D; Hermeking H
Gastroenterology; 2017 Aug; 153(2):505-520. PubMed ID: 28435028
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
[TBL] [Abstract][Full Text] [Related]
8. Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer.
Ni Q; Li M; Yu S
Technol Cancer Res Treat; 2022; 21():15330338221081219. PubMed ID: 35435774
[TBL] [Abstract][Full Text] [Related]
9. CD31 and D2-40 Contribute to Peritoneal Metastasis of Colorectal Cancer by Promoting Epithelial-Mesenchymal Transition.
Zhu X; Zhou G; Ni P; Jiang X; Huang H; Wu J; Shi X; Jiang X; Liu J
Gut Liver; 2021 Mar; 15(2):273-283. PubMed ID: 32390409
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer.
Zafari N; Velayati M; Nassiri M; Khazaei M; Hassanian SM; Ferns GA; Avan A
Curr Pharm Des; 2022; 28(28):2298-2311. PubMed ID: 35909286
[TBL] [Abstract][Full Text] [Related]
11. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis.
Yang C; Dou R; Wei C; Liu K; Shi D; Zhang C; Liu Q; Wang S; Xiong B
Mol Ther; 2021 Jun; 29(6):2088-2107. PubMed ID: 33571679
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways.
Sabouni E; Nejad MM; Mojtabavi S; Khoshduz S; Mojtabavi M; Nadafzadeh N; Nikpanjeh N; Mirzaei S; Hashemi M; Aref AR; Khorrami R; Nabavi N; Ertas YN; Salimimoghadam S; Zandieh MA; Rahmanian P; Taheriazam A; Hushmandi K
Biomed Pharmacother; 2023 Apr; 160():114395. PubMed ID: 36804124
[TBL] [Abstract][Full Text] [Related]
15. miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.
Zheng YB; Luo HP; Shi Q; Hao ZN; Ding Y; Wang QS; Li SB; Xiao GC; Tong SL
World J Gastroenterol; 2014 Jun; 20(21):6515-22. PubMed ID: 24914372
[TBL] [Abstract][Full Text] [Related]
16. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells.
Fan F; Samuel S; Evans KW; Lu J; Xia L; Zhou Y; Sceusi E; Tozzi F; Ye XC; Mani SA; Ellis LM
Cancer Med; 2012 Aug; 1(1):5-16. PubMed ID: 23342249
[TBL] [Abstract][Full Text] [Related]
18. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
Xin H; Wang C; Liu Z
BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]